Supernus Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Supernus Pharmaceuticals (SUPN) Tops Q2 EPS by 1c, Updates Guidance
August 5, 2015 8:24 AM EDTSupernus Pharmaceuticals (NASDAQ: SUPN) reported Q2 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $35.1 million versus the consensus estimate of $34.27 million.
Financial Guidance
The Company is updating its full year 2015 financial guidance for both expected net... More
